Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Low Field Magnetic Stimulation Treatment for Bipolar Depression [Phase 3]
Phase 3 trial evaluating Low Field Magnetic Stimulation for bipolar depression was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology [NA]
This completed study investigated the effects of quetiapine on ultrastructural hippocampal changes and neurochemical alterations in patients…
-
FDA approval · 2012-03-12FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for risperidone (Risperidone) by Janssen Pharmaceutical, Inc. The approval signals changes or additi…
-
CLINICAL_TRIALS withdrawal · 2012-03-12Clinical Trial Update: Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation [NA]
A clinical trial investigating brain bioenergetics in bipolar disorder (and schizophrenia) in response to photic stimulation has been withdr…
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE LITHIUM CARBONATE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for Alembic Pharmaceuticals to market a generic lithium carbonate product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals' supplemental application for lithium carbonate, updating the existing product approval. The snippet d…
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lithium carbonate submitted by Camber Pharmaceuticals, Inc.
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lithium carbonate filed by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium Carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder [Phase 4]
A Phase 4 trial evaluating fluoxetine for pediatric bipolar disorder with comorbid pediatric obsessive-compulsive disorder was terminated, w…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of extended-release paliperidone vs placebo to delay recurrence of symptoms in Bipolar…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder [Phase 2]
Phase 2 trial evaluating the safety and efficacy of memantine for acute mania in Bipolar I Disorder has completed.
-
FDA approval · 2012-03-02FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for a generic ziprasidone hydrochloride product, enabling a generic version of this antipsy…
-
FDA approval · 2012-03-02FDA Approved: ZIPRASIDONE — Original Application (Dr. Reddy's Laboratories Limited)
The FDA approved Dr. Reddy's Laboratories Limited's generic Ziprasidone as an original ANDA, enabling a generic version of the antipsychotic…
-
FDA approval · 2012-03-01FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA granted Westminster Pharmaceuticals, LLC a supplemental approval for risperidone, updating the approved product's labeling.
-
FDA label_change · 2012-02-28FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lamotrigine by Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Lithium for the Treatment of Pediatric Mania [Phase 2]
Phase 2 trial evaluating lithium carbonate for pediatric mania in Bipolar I Disorder without psychotic symptoms has completed.
-
FDA approval · 2012-02-27FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2012-02-21FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for risperidone from Sun Pharmaceutical Industries, Inc. under an Abbreviated New Drug Application, …
-
CLINICAL_TRIALS research · 2012-02-09Clinical Trial Update: Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
McMaster University is conducting a longitudinal study of people presenting for their first treatment of mood disorders, including major dep…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating supraphysiological doses of levothyroxine as adjunctive therapy for bipolar depression.
-
FDA approval · 2012-01-31FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, expanding the lamotrigine product offering. The approv…
-
FDA approval · 2012-01-30FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for a generic risperidone product from Amneal Pharmaceuticals LLC. Risperidone is an antipsychot…
-
FDA approval · 2012-01-30FDA Approved: OLANZAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic olanzapine under an Original Application, establishing a generic version of the antipsychotic for schizophrenia …
-
FDA approval · 2012-01-30FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic risperidone from Aurobindo Pharma Limited, granting approval for a generic version of …